 
Community Cancer Care (CCC) is committed
to providing our physicians and patients with access to state-of-the-art
treatment protocols for many forms of cancer. The
Department of Clinical Trials exemplifies this commitment.
Please browse our database of available clinical trials and contact us
with any questions you may have.
In addition, CCC is proud to participate
in the National Cancer Institute Breast
Cancer Prevention(P2) Study of tamoxifen and raloxifene (STAR).
|
|
